TABLE II.
Low titer |
Moderate titer |
High titer |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Age (yr) | N | Positive | % | 1:25 | 1:50 | 1:100 | 1:200 | 1:400 | 1:800 | 1:1,600 | 1:3,200 | Median (log) |
0.5–1† | 10 | 0 | 0.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
1–4 | 124 | 1 | 0.8 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1:25 |
5–9 | 219 | 6 | 2.7 | 0 | 2 | 2 | 0 | 0 | 0 | 0 | 2 | 1:200 |
10–14 | 124 | 14 | 11.3 | 0 | 2 | 0 | 2 | 0 | 1 | 0 | 9 | 1:800 |
≥15‡ | 169 | 46 | 27.2 | 3 | 3 | 1 | 4 | 8 | 8 | 4 | 15 | 1:800 |
Pooled data from males and females, as no sex-specific differences in seroprevalence or titer were observed (see Table I).
All seropositive neonate samples were from seropositive mothers.
Pools data from Kolle and Bamako, as no differences were observed in anti–T. gondii seropositivity (see Table I).